Navigation Links
BioMarin Announces Second Quarter 2011 Financial Results
Date:7/28/2011

$15

$14 to $18Selected Income Statement Guidance ($ in millions)Item

2011 Guidance

Previous 2011 GuidanceCost of Sales (% of Total Revenue)

Unchanged

18% to 20%Selling, General and Admin. Expense

Unchanged

$164 to $174Research and Development Expense

$200 to $205

$195 to $205Amortization and Contingent Consideration

$2

$15Interest Income

Unchanged

$3Income Tax Expense (Benefit)

$14

$15GAAP Net Income (Loss)

$(43) to $(33)

$(52) to $(42)Stock Compensation Expense

$45

$43Non-GAAP Adjusted EBITDA

$49 to $59

$51 to $61Anticipated Upcoming Milestones3Q 2011/4Q 2011: Top-line results for Phase II trial for PEG-PAL, including daily dosing and formulation studies
1Q 2012/2Q 2012: Initiation of Phase III trial for PEG-PAL
1Q 2012: Initiation of Phase I trial for BMN-111 for Achondroplasia
2H 2012: Top-line results for Phase III trial for GALNS for MPS IVA
2H 2012: Top-line results for PKU-016 Kuvan neurocognitive study
2H 2012: Top-line results for Phase I/II trial for BMN-701 for Pompe disease
4Q 2012/1Q 2013: Market authorization application filings for GALNS for MPS IVA
1Q 2013-3Q 2013: 510k clearance and commercial availability of the handheld blood Phe monitor for PKU

Research and Development ProgramsBioMarin continues to make significant investments in research and development to ensure persistent growth of the company.  The current pipeline includes programs in various stages of development that are focused on treating a range of serious unmet medical needs.Advanced Clinical Programs

  • GALNS for MPS IVA: BioMarin is enrolling patients in the randomized, double-blind, placebo-controlled Phase III study with primary endpoint of six-minute walk distance, 24 weeks in treatment duration and treatment doses of two mg/kg/week and two mg/kg/every other week.  The company exp
    '/>"/>

  • SOURCE BioMarin Pharmaceutical Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
    2. BioMarin Announces FDA Approval for Kuvan
    3. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
    4. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
    5. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
    6. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
    7. BioMarin Acquires Huxley Pharmaceuticals, Inc.
    8. BioMarin to Present at the Oppenheimer Healthcare Conference
    9. BioMarin Announces Third Quarter 2009 Financial Results
    10. BioMarin to Acquire LEAD Therapeutics
    11. BioMarin to Present at the Credit Suisse Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2015)... Washington , 29. Juli 2015 /PRNewswire/ ... Diabeteszentrums wurde festgestellt, dass die tägliche Einnahme ... Nutraceutix die menschliche Darmflora anreichert und die ... erhöhen. Die Studie umfasste die tägliche Einnahme ... SD-5865) in Tablettenform unter Verwendung der patentierten ...
    (Date:7/29/2015)... Nev. , July 29, 2015  PDL BioPharma, ... has entered into a revenue interest assignment agreement (the ... Pharmaceuticals, Inc. (NASDAQ: ARIA ) with up to ... royalties on the net revenues of Iclusig ® ... made in two tranches of $50 million each, with ...
    (Date:7/29/2015)... 29, 2015 Touro College has announced that it ... for one of five media marijuana licenses to be issued ... of Health (DOH).  If CanniCare is selected, ... "Our college is supportive of medicinal development ... the Touro College System. "There is still a great deal ...
    Breaking Medicine Technology:Klinischer Nachweis erbracht, dass L. reuteri Probiotikum von Nutraceutix den Darm-Insulinmetabolismus moduliert 2PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 2PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 3PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 4PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 5Touro College Announces Support for CanniCare's Medical Cannabis License Application 2
    ... 18, 2011 Reportlinker.com announces that a ... its catalogue: Cervarix (Cervical ... http://www.reportlinker.com/p0657234/Cervarix-Cervical-Cancer---Analysis-and-Forecasts-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... Forecasts to 2020 Summary ...
    ... N.Y., Oct. 18, 2011 Henry Schein, Inc. ... care products and services to office-based practitioners, announced today that ... the stock market opens on Tuesday, November 1, 2011, and ... on the same day beginning at 10:00 a.m. Eastern Daylight ...
    Cached Medicine Technology:Cervarix (Cervical Cancer) - Analysis and Forecasts to 2020 2Cervarix (Cervical Cancer) - Analysis and Forecasts to 2020 3Cervarix (Cervical Cancer) - Analysis and Forecasts to 2020 4Henry Schein to Webcast Third Quarter 2011 Conference Call Tuesday, November 1, at 10:00 a.m. EDT 2
    (Date:7/29/2015)... ... July 29, 2015 , ... The NCCA ... five-year period, expiring November 30, 2019, during its recent meeting. , The Commission ... demonstrating the program’s compliance with the NCCA’s Standards for the Accreditation of Certification ...
    (Date:7/29/2015)... ... 29, 2015 , ... On July 26th the Miami ... for nicotine laced liquid products. Their report says cigarette use has decreased recently ... particularly troublesome to addiction professionals as many of the candy flavors available are ...
    (Date:7/29/2015)... Waukesha, WI (PRWEB) , ... July 29, 2015 ... ... area, Scott Campbell Agency has once again teamed up with Stillwaters Cancer Support ... patients and their families. Stillwaters provides individual and family counseling, support groups, workshops ...
    (Date:7/29/2015)... ... 2015 , ... For the second year in a row, the management and ... 50 fastest growing companies in Jacksonville. This annual list is compiled by the Jacksonville ... team of Vast Bridges staffers were on hand to receive the award naming the ...
    (Date:7/29/2015)... ... July 29, 2015 , ... We are privileged to announce that U.S. News ... as the ninth best ophthalmology hospital in the nation for 2015-2016. This marks the 21st ... for ophthalmology. , “It is an honor to be included in the top 10 ...
    Breaking Medicine News(10 mins):Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 2Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 3Health News:Vast Bridges Continues Its Swift Growth 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3
    ... doctor/patient ratios, experts say , , THURSDAY, March 26 (HealthDay ... United States may soon face shortages of access to ... a new study warns. , Researchers found that ... communities, a trend that could lead to shortages in ...
    ... Today, in Roach v. Stouffer , the ... acted unconstitutionally when they denied a valid petition for ... viewpoint. The court also ordered the specialty plate ... "It is encouraging that more and more states like ...
    ... Two researchers from NYU School of Medicine have been ... Institute (HHMI). The honorees, Iannis Aifantis, Ph.D. associate professor ... at the NYU Cancer Institute and Jeremy S. Dasen ... School of Medicine are among 50 of the nation,s ...
    ... March 26 Two Miami-area residents pleaded guilty today ... involving HIV infusion clinics, Acting Assistant Attorney General Rita ... R. Alexander Acosta of the Southern District of Florida ... 44, each pleaded guilty to one count of conspiracy ...
    ... today by the Democratically-controlled Michigan House of Representatives ... of personal injury lawyers at the expense of ... repealing Michigan,s lawsuit abuse protections, the supporters of ... a lawsuit magnet," said Wendy Block, Director of ...
    ... medicine services for physicians and patients in partnership ... March 26 El Camino Hospital, the hospital ... of guidance and decision support for genomic medicine, ... the first community hospital in the nation to ...
    Cached Medicine News:Health News:Midwest and Northeast May Face Surgeon Shortage 2Health News:Americans United for Life Applauds Ruling Directing Missouri to Issue 'Choose Life' Plate 2Health News:Two NYU Scientists Named Howard Hughes Medical Institute's early career scientists 2Health News:Two NYU Scientists Named Howard Hughes Medical Institute's early career scientists 3Health News:Miami Doctor and Chemist Plead Guilty in HIV Infusion Fraud Scheme 2Health News:Miami Doctor and Chemist Plead Guilty in HIV Infusion Fraud Scheme 3Health News:El Camino Hospital Launches Genomic Medicine Institute 2Health News:El Camino Hospital Launches Genomic Medicine Institute 3Health News:El Camino Hospital Launches Genomic Medicine Institute 4
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    Medicine Products: